Allergy and Immunology · Mayfield Heights, OH
NPI
1730159674
Since 2006
Specialty
Allergy and Immunology
Code 207K00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
5915 Landerbrook Dr, Ste. 110 Allergy Immunology Assoc., Inc.
Mayfield Heights, OH, 44124
Phone (216) 381-3333
Groups this clinician bills Medicare through
Medicare paid, 2024
$7.5M
121,268 services
Medicare patients, 2024
310
Average age 72
Drug cost, 2024
$7.2M
2,954 prescriptions
Company payments, 2025
$4,183
From 30 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Robert W Hostoffer was code J1556 (injection, immune globulin (bivigam), 500 mg), 51,932 times for 51 patients. In total Robert W Hostoffer billed 121,268 services in 73 codes, and Medicare paid $7.5M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-01-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1556 Injection, immune globulin (bivigam), 500 mg | Office | 51,932 | 51 | $57.96 | $3.0M |
| J1554 Injection, immune globulin (asceniv), 500 mg | Office | 8,518 | 11 | $385.26 | $3.3M |
| J2357 Injection, omalizumab, 5 mg | Office | 4,680 | 11 | $26.02 | $122K |
| J2919 Injection, methylprednisolone sodium succinate, 5 mg | Office | 3,404 | 39 | $0.23 | $766 |
| 96366 Intravenous Infusion, Hydration | Office | 1,725 | 66 | $14.02 | $24K |
| J1201 Injection, cetirizine hydrochloride, 0.5 mg | Office | 1,620 | 12 | $11.52 | $19K |
| 96365 Intravenous Infusion, Hydration | Office | 809 | 68 | $42.04 | $34K |
| 95004 Test - Miscellaneous | Office | 763 | 24 | $2.61 | $1,995 |
| 96375 Injection Administration | Office | 697 | 44 | $10.51 | $7,328 |
| 95165 Treatment - Miscellaneous | Office | 511 | 33 | $9.56 | $4,884 |
| 99214 Office E&M - Established | Office | 399 | 204 | $89.59 | $36K |
| 96372 Injection Administration | Office | 396 | 45 | $9.53 | $3,774 |
| 95117 Treatment - Miscellaneous | Office | 348 | 33 | $7.52 | $2,615 |
| 95024 Test - Miscellaneous | Office | 134 | 17 | $5.66 | $758 |
| 95115 Treatment - Miscellaneous | Office | 103 | 14 | $6.20 | $638 |
By year: 2022 $3.6M for 106,670 services; 2023 $4.9M for 110,874 services; 2024 $7.5M for 121,268 services.
Medicare prescription drug claims, 2024
In 2024, the drug Robert W Hostoffer prescribed most often to Medicare patients was Azelastine Hcl, with 267 prescriptions and refills. In total Robert W Hostoffer wrote 2,954 Medicare prescriptions that cost $7.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Azelastine Hcl Generic | 267 | 481 | 93 | $9,168 |
| Montelukast Sodium Generic | 210 | 511 | 55 | $1,759 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 137 | 180 | 68 | $3,495 |
| Famotidine Generic | 130 | 253 | 41 | $1,385 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 101 | 169 | 22 | $1,315 |
| Ipratropium Bromide Generic | 81 | 139 | 27 | $3,476 |
| Fluticasone Propionate Generic | 75 | 147 | 25 | $997 |
| Prednisone Generic | 65 | 79 | 26 | $664 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 62 | 79 | 16 | $51K |
| Epinephrine Generic | 62 | 64 | 22 | $9,504 |
| Hydroxychloroquine Sulfate Generic | 59 | 121 | 11 | $1,324 |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 54 | 64 | 14 | $39K |
| Doxycycline Hyclate Generic | 54 | 54 | 38 | $565 |
| Omeprazole Generic | 51 | 107 | 19 | $804 |
| Symbicort Budesonide/Formoterol Fumarate | 50 | 106 | 18 | $24K |
Brand drugs: - claims; generic drugs: 2,151 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Robert W Hostoffer $4,183 ($4,183 in general payments such as food, travel and fees) from 30 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $709.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 19 | $709 |
| CSL Behring CSL.AX | 17 | $384 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 13 | $355 |
| Novartis Pharmaceuticals Corporation NVS | 13 | $267 |
| GlaxoSmithKline, LLC. GSK | 16 | $262 |
| Amgen Inc. AMGN | 15 | $257 |
| Genzyme Corporation SNY | 8 | $217 |
| Sanofi-Aventis U.S. LLC SNY | 2 | $194 |
| Octapharma USA, Inc. | 9 | $183 |
| Verona Pharma, Inc. VRNA | 5 | $136 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.